ExThera Medical

ExThera Medical

CA - Martinez
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Blood filtration

ExThera Medical is a life sciences company focused on Blood filtration.

Infectious DiseasesCardiovascularOncologyOphthalmologyNephrology
Funding Stage
PUBLIC
Open Jobs
0

Products & Portfolio (1)

OMLONTI
omidenepag isopropyl
Peak
OPHTHALMIC · SOLUTION
EP2 receptor agonist which decreases intraocular pressure (IOP). The exact mechanism of action is unknown at this time. Elevated IOP represents a major risk factor for glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss.
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertensionhypertension
2022
0

Pipeline & Clinical Trials

Seraph 100 Filter
Bacteremia
N/A
Clinical Trials (1)
NCT02914132Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis
N/A
Seraph 100,The Microbind Affinity Blood Filter
Bloodstream Infection
N/A
Clinical Trials (1)
NCT04260789Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection
N/A
Extracorporal therapy
Kidney Diseases
N/A
Clinical Trials (1)
NCT04984902Reduction of BK Viremia in Kidney Transplant Patients
N/A
Seraph®-100 Microbind® Affinity Blood Filter
COVID-19
N/A
Clinical Trials (1)
NCT04413955Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA
N/A
Seraph 100
COVID-19
N/A
Clinical Trials (1)
NCT04547257Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19
N/A
N/A
Clinical Trials (1)
NCT06655142OSCAR II STUDY - The ONCObind CTC Removal Study
N/A
Seraph® 100 Microbind® Affinity Blood Filter
Long COVID
N/A
Clinical Trials (1)
NCT06637800Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)
N/A
N/A
Clinical Trials (1)
NCT06481397OSCAR I STUDY - The ONCObind CTC Removal Study
N/A
Seraph-100 + State of the Art Care
Septic Shock
N/A
Clinical Trials (1)
NCT05011656Blood Purification for the Treatment of Pathogen Associated Shock
N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2007
Portfolio: 1 approved product, 9 clinical trials
Top TAs: Infectious Diseases, Oncology, Cardiovascular
H-1B (2023): 1 approval
Publications: 5 in PubMed
Portfolio Health
Peak1 (100%)
1 total products
Therapeutic Area Focus
Oncology
2 pipeline
Cardiovascular
1 marketed
Ophthalmology
1 marketed
Nephrology
1 pipeline
Marketed
Pipeline

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub